Par Drugs & Chemicals announced that the 25th Annual General Meeting (AGM) of the company will be held on 21 September 2024.Powered by Capital Market - Live News

Par Drugs & Chemicals will hold a meeting of the Board of Directors of the Company on 17 August 2024.Powered by Capital Market - Live News

Net profit of Par Drugs & Chemicals rose 2.43% to Rs 2.53 crore in the quarter ended June 2024 as against Rs 2.47 crore during the previous quarter ended June 2023. Sales declined 1.40% to Rs 22.61 crore in the quarter ended June 2024 as against Rs 22.93 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales22.6122.93 -1 OPM %18.7118.05 - PBDT4.284.13 4 PBT3.383.30 2 NP2.532.47 2 Powered by Capital Market - Live News

Par Drugs & Chemicals will hold a meeting of the Board of Directors of the Company on 3 August 2024.Powered by Capital Market - Live News

Net profit of Par Drugs & Chemicals rose 7.83% to Rs 3.72 crore in the quarter ended March 2024 as against Rs 3.45 crore during the previous quarter ended March 2023. Sales declined 6.82% to Rs 22.82 crore in the quarter ended March 2024 as against Rs 24.49 crore during the previous quarter ended March 2023.For the full year,net profit rose 27.98% to Rs 14.50 crore in the year ended March 2024 as against Rs 11.33 crore during the previous year ended March 2023. Sales declined 0.11% to Rs 95.64 crore in the year ended March 2024 as against Rs 95.75 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales22.8224.49 -7 95.6495.75 0 OPM %26.7322.01 -23.8719.01 - PBDT6.005.39 11 22.9618.31 25 PBT5.114.54 13 19.5215.08 29 NP3.723.45 8 14.5011.33 28 Powered by Capital Market - Live News